The Advisory Board Company

Paul Martino, Co-Founder of VillageMD, Joins Forge Health as Chairman of the Board

Retrieved on: 
Wednesday, December 13, 2023

Forge Health (“Forge” or the “Company”), a leading provider of value-based mental health and substance use care, today announced that accomplished health services executive Paul Martino has been appointed to its board of directors as the new Chairman.

Key Points: 
  • Forge Health (“Forge” or the “Company”), a leading provider of value-based mental health and substance use care, today announced that accomplished health services executive Paul Martino has been appointed to its board of directors as the new Chairman.
  • View the full release here: https://www.businesswire.com/news/home/20231213023130/en/
    Paul Martino, Forge Health Chairman of the Board (Photo: Business Wire)
    “I’m thrilled to join the Forge Health team during this exciting time of transformation in the healthcare industry," said Mr. Martino.
  • “Forge Health’s behavioral health care model has been validated by a national payor.
  • Through growing population health partnerships with leading health plans and health systems, it now manages more than 300,000 members under its value-based partnership model.

Vida Health Announces $28.5 Million in Funding; Appoints Joe Murad CEO

Retrieved on: 
Thursday, November 9, 2023

The Company also announced the appointment of Joe Murad as Chief Executive Officer, effective immediately.

Key Points: 
  • The Company also announced the appointment of Joe Murad as Chief Executive Officer, effective immediately.
  • Murad succeeds Stephanie Tilenius, who will step down following nine years of service as Founder and Chief Executive Officer and will transition to an advisory capacity.
  • Vida intends to use the investment to further scale and pursue ongoing growth opportunities, particularly in the rapidly expanding GLP-1 market.
  • He most recently served as President and CEO of WithMe Health, a digital health company offering pharmacy benefits management and personalizing medication experiences for employers, employees, and their families.

Kalamazoo Valley Community College Appoints Two Interim Board Members

Retrieved on: 
Tuesday, December 12, 2023

KALAMAZOO, Mich., Dec. 12, 2023 /PRNewswire-PRWeb/ -- Kalamazoo Valley Community College Appoints Two Interim Board Members

Key Points: 
  • The Kalamazoo Valley Community College Board of Trustees has appointed two new provisional board members who will serve on the college's board for one year, from Jan. 1 through Dec. 31, 2024.
  • The Kalamazoo Valley Community College Board of Trustees has appointed two new provisional board members who will serve on the college's board for one year, from Jan. 1 through Dec. 31, 2024.
  • She has also used her advanced training in political philosophy, law, and ethics to teach students at seven different universities including Western Michigan University, DePaul University and Kalamazoo College.
  • Purnell and Thomas-Cloud have been appointed to replace board members Susan L. Miller and Patrick A.

HOONIGAN APPOINTS VANCE JOHNSTON AS PRESIDENT TO LEAD THE COMPANY IN ITS NEXT PHASE OF GROWTH AND ANNOUNCES RETIREMENT OF RANDY WHITE AS CEO

Retrieved on: 
Tuesday, December 12, 2023

DENVER and SANTA MONICA, Calif., Dec. 11, 2023 /PRNewswire/ -- Hoonigan (the "Company"), a provider of high-performance aftermarket vehicle enhancements backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake"), today announced that the Company's Board of Directors (the "Board") has appointed Vance Johnston as President and Chief Operating Officer. In his new role, Johnston will report exclusively to the Board and will manage all aspects of Hoonigan's operations as the Company continues to execute its strategic vision.

Key Points: 
  • He succeeds Co-Founder and former Chief Executive Officer Randy White, who announced his retirement after almost 30 years of driving the Company and the automotive aftermarket industry forward.
  • White will continue to serve on the Board and be closely involved in the transition as an advisor.
  • "Randy is an inspiring leader who has progressed both Hoonigan and the industry forward since the Company's inception.
  • "I'm confident Vance is the right person to lead Hoonigan into the future and deliver its next phase of growth.

Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments

Retrieved on: 
Monday, December 4, 2023

MENLO PARK, Calif., Dec. 4, 2023 /PRNewswire/ -- Enavate Sciences , a portfolio company of Patient Square Capital , is pleased to announce that Sara M. Nayeem, M.D.

Key Points: 
  • MENLO PARK, Calif., Dec. 4, 2023 /PRNewswire/ -- Enavate Sciences , a portfolio company of Patient Square Capital , is pleased to announce that Sara M. Nayeem, M.D.
  • has joined the firm as Executive Vice President, Investments.
  • Dr. Nayeem reports to James Boylan, Chief Executive Officer of Enavate Sciences, and will serve an integral role in the origination, evaluation, and selection of Enavate investments, as well as support Enavate partner companies on governance, partnerships, fundraising, and other strategic initiatives.
  • She most recently served as Partner at Avoro Ventures, a biopharma venture fund she helped launch in 2021.

Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation

Retrieved on: 
Wednesday, November 29, 2023

WakeMed recognized that it had the opportunity to decrease clinical variations in care that could help improve patient outcomes.

Key Points: 
  • WakeMed recognized that it had the opportunity to decrease clinical variations in care that could help improve patient outcomes.
  • WakeMed's clinical transformation teams use the data and analytics to identify, understand, and quantify opportunities for improvement.
  • "The Health Catalyst analytics platform gives us the actionable data we need to support clinical transformation.
  • Commenting on WakeMed's achievement, Health Catalyst CEO Dan Burton said, "We're thrilled for the success of WakeMed and its clinical transformation teams.

MedGenome appoints Martin Dewhurst as Chairman of Advisory Board

Retrieved on: 
Tuesday, November 28, 2023

FOSTER CITY, Calif., Nov. 28, 2023 /PRNewswire/ -- MedGenome , a global precision medicine company specializing in omics solutions today announced the appointment of Martin Dewhurst, a McKinsey veteran for over 30 years as the Chairman of its Advisory Board.

Key Points: 
  • FOSTER CITY, Calif., Nov. 28, 2023 /PRNewswire/ -- MedGenome , a global precision medicine company specializing in omics solutions today announced the appointment of Martin Dewhurst, a McKinsey veteran for over 30 years as the Chairman of its Advisory Board.
  • In his capacity as Chairman of the Advisory Board, Martin will work closely with MedGenome's Research services team in the US to build strong connects with the global life sciences community.
  • We are thrilled to welcome Martin Dewhurst as the Chair of our Advisory Board at MedGenome.
  • Martin Dewhurst , Chair of Advisory Board, MedGenome said, "I believe that omics will anchor the future of the life sciences sector and MedGenome will play a crucial role in this journey.

SG Analytics Welcomes Martina Macpherson to Advisory Board, Supporting its Vision of Transformative Growth in Sustainable Finance

Retrieved on: 
Wednesday, November 8, 2023

SG Analytics, a globally renowned Insights and Analytics powerhouse, proudly announces the appointment of Martina Macpherson to its distinguished Advisory Board.

Key Points: 
  • SG Analytics, a globally renowned Insights and Analytics powerhouse, proudly announces the appointment of Martina Macpherson to its distinguished Advisory Board.
  • In a move that promises to reshape the ESG landscape, Martina will play a pivotal role in supporting SGA's global vision for leadership in sustainable finance.
  • View the full release here: https://www.businesswire.com/news/home/20231108963406/en/
    Martina Macpherson Joins SG Analytics as an Advisory Board Member (Photo: Business Wire)
    Martina Macpherson brings over two decades of expertise in the realm of sustainable finance, earning accolades as an ESG luminary, researcher, innovator, and entrepreneur.
  • Her dedication to sustainable finance and leadership led to her recognition as one of the 'Top 50 Women in Finance' by the World Finance Forum (WFF) in 2022.

iDonate, a Leading Digital fundraising solution provider for nonprofits, appoints Brad Little as Chief Executive Officer

Retrieved on: 
Wednesday, November 8, 2023

iDonate, Inc., the leading provider of donor-centric, high performing digital fundraising solutions for nonprofits, today announced that Brad Little has been appointed Chief Executive Officer.

Key Points: 
  • iDonate, Inc., the leading provider of donor-centric, high performing digital fundraising solutions for nonprofits, today announced that Brad Little has been appointed Chief Executive Officer.
  • View the full release here: https://www.businesswire.com/news/home/20231108134317/en/
    Brad Little appointed Chief Executive Officer for iDonate.
  • He spent nearly five years at Blackbaud leading their payments and online giving business units.
  • Nearly all iDonate customers have transitioned to the new 2.0 platform in less than a year, leveraging best-in-class fundraising tools.

Apollo Medical Holdings, Inc. Announces Definitive Agreement to Acquire Assets of Community Family Care Medical Group IPA, Inc. and Health Plan

Retrieved on: 
Tuesday, November 7, 2023

CFC's scaled provider group, with more than 350 primary care physicians and 500 specialists on platform, manages the healthcare of over 200,000 members in the Los Angeles, California area.

Key Points: 
  • CFC's scaled provider group, with more than 350 primary care physicians and 500 specialists on platform, manages the healthcare of over 200,000 members in the Los Angeles, California area.
  • CFC, which became an ApolloMed Care Enablement client in 2020, has a Restricted Knox Keene ("RKK") license for Medicaid members, and will seamlessly integrate as an ApolloMed Care Partner as it continues to utilize our Care Enablement platform.
  • We believe that pairing CFC's impressive track record and clinical capabilities with ApolloMed's scaled value-based care platform will result in even better outcomes for those we serve.
  • CFC's adjusted EBITDA for the full year is expected to be approximately $25 million, reflecting a margin of approximately 13%.